North Rock Partners, LLC Eli Lilly & CO Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, North Rock Partners, LLC holds 4,353 shares of LLY stock, worth $3.61 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,353

Previous 5,399 19.37%

Holding current value

$3.61 Million

Previous $4.89 Million 21.11%

% of portfolio

0.34%

Previous 0.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $807,658 - $1 Million	-1,046 Reduced 19.37%	4,353 $3.86 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $381,281 - $478,155	-526 Reduced 8.88%	5,399 $4.89 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $340,515 - $455,561	575 Added 10.75%	5,925 $4.61 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $92,433 - $108,966	176 Added 3.4%	5,350 $3.12 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $486,429 - $670,616	1,119 Added 27.6%	5,174 $2.78 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $119,602 - $159,922	-341 Reduced 7.76%	4,055 $1.9 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $244,155 - $286,748	-786 Reduced 15.17%	4,396 $1.51 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $335,376 - $390,780	1,043 Added 25.2%	5,182 $1.9 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $64,336 - $73,317	217 Added 5.53%	4,139 $1.34 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $74,142 - $87,053	266 Added 7.28%	3,922 $1.27 Million
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $67,356 - $83,706	-287 Reduced 7.28%	3,656 $1.05 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $262,175 - $325,360	1,166 Added 41.99%	3,943 $1.09 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $116,118 - $142,900	524 Added 23.26%	2,777 $642,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $121,690 - $157,405	674 Added 42.69%	2,253 $517,000
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $16,267 - $21,059	99 Added 6.69%	1,579 $295,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $38,224 - $50,580	-293 Reduced 16.53%	1,480 $250,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $28,512 - $32,980	195 Added 12.36%	1,773 $262,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $136 - $164	-1 Reduced 0.06%	1,578 $259,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $57,842 - $69,612	-424 Reduced 21.17%	1,579 $259,000
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $322,268 - $398,876	-2,707 Reduced 57.47%	2,003 $278,000
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $636,067 - $787,826	-5,949 Reduced 55.81%	4,710 $619,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $1.14 Million - $1.41 Million	10,659 New	10,659 $619,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Eli Lilly & CO Transaction History